Scientifically reviewed by Dr Stephan Hansberg
HPLC vs mass spectrometry for peptides: purity vs identity
Why HPLC measures purity and mass spectrometry confirms identity, how truncated and deletion sequences can slip through a UV purity test, and what LC-MS adds to a peptide certificate.
Key takeaways
- •HPLC separates a sample and reports the main peak's share of UV absorbance: a purity measure. Mass spectrometry weighs the molecules: an identity measure.
- •A deletion sequence (one amino acid missing) can have almost the same hydrophobicity as the target and elute under or beside the main peak, inflating an HPLC purity figure.
- •LC-MS couples the two, so each peak can be assigned a mass, and co-eluting impurities can be seen as extra masses under one peak.
- •Neither technique measures how many mg are in a container unless it is calibrated against a reference standard.
- •When comparing certificates, note which method was used for which claim rather than reading a single headline number.
The short answer
HPLC tells you how clean a peptide sample is; mass spectrometry tells you what the main molecule actually is. HPLC purity is a ratio of peak areas, so a sample can score 99% and still be the wrong molecule or hide closely related impurities, while a mass result confirms that the molecular weight matches the intended sequence. A strong certificate uses both, ideally together as LC-MS.
How HPLC purity is measured
Peptide purity is usually measured by reversed-phase high-performance liquid chromatography (RP-HPLC). The sample is pumped through a column packed with a hydrophobic stationary phase, commonly C18, while the mobile phase gradually changes from mostly water to mostly acetonitrile. More hydrophobic molecules are retained longer, so components leave the column at different times.
A UV detector records absorbance as each component elutes, most often at around 214 to 220 nm where the peptide bond absorbs. The software integrates the area under each peak, and purity is the main peak's area as a percentage of the total. This is relative, not absolute: it assumes every component absorbs similarly at that wavelength, and it ignores anything that does not absorb UV, such as water and many salts.
How mass spectrometry confirms identity
A mass spectrometer turns molecules into ions, commonly by electrospray ionisation for peptides, and measures their mass-to-charge ratio. Peptides typically pick up several protons and appear at several charge states, which software deconvolutes into one neutral molecular mass. That measured mass is compared with the theoretical mass of the sequence.
Mass differences are diagnostic. A missing glycine shifts the mass by about 57 Da, a missing proline by about 97 Da, and deamidation of asparagine or glutamine by about +1 Da. Oxidation of methionine adds about 16 Da. A mass spectrum can therefore not only confirm the target but also name likely impurities.
| HPLC-UV | Mass spectrometry | LC-MS (both) | |
|---|---|---|---|
| Main question answered | Purity (relative) | Identity (molecular mass) | Purity and identity per peak |
| Output | Chromatogram, % area | Spectrum, measured mass | Chromatogram with a mass for each peak |
| Sees water and most salts? | No | No (not as part of the peptide mass) | No |
| Detects co-eluting impurities? | Only if they separate | Yes, as extra masses | Yes |
| Gives mg content? | Only against a reference standard | Not routinely | Only against a reference standard |
Why deletion and truncated sequences can pass HPLC
Solid-phase peptide synthesis builds a chain one amino acid at a time. If a coupling step is incomplete, some chains miss one residue and continue growing, producing a deletion sequence. If a chain stops growing altogether, it becomes a truncated sequence. Incomplete removal of protecting groups, deamidation and oxidation add further related impurities. A 2014 review of peptide medicines lists these as the main classes of related impurity.
The difficulty is that a peptide missing one residue out of fifteen is chemically very similar to the full sequence. Its hydrophobicity can be close enough that, under a given gradient, it elutes under the main peak or on its shoulder. HPLC then counts it as part of the target, and the purity figure goes up rather than down. Instrument makers' application notes make the same point: a clean UV trace cannot by itself exclude co-eluting impurities, and accurate-mass MS is used to check peak purity. A 2026 Waters application note describes a proline insertion impurity in exenatide that co-eluted with the native peptide under reversed-phase conditions.
This is the main reason a high HPLC number should be read as necessary but not sufficient evidence of quality.
What LC-MS adds
LC-MS sends the column output into a mass spectrometer, so every peak in the chromatogram has a mass attached. Analysts can extract the signal for a specific expected impurity mass and see whether it sits under the main peak, and they can tell whether a small peak is a synthesis by-product or a degradation product. For a certificate reader, an LC-MS result answers the identity question directly and gives more confidence that the purity figure is not inflated by hidden related sequences.
LC-MS has limits too. Some impurities ionise poorly, isomers with identical mass (for example a D-amino acid in place of an L-amino acid) are not distinguished by mass alone, and quantification still needs reference standards.
Orthogonal methods and why one HPLC run is not the whole story
Analysts call two methods orthogonal when they separate or detect compounds by different properties. Reversed-phase HPLC separates by hydrophobicity, so an impurity with almost the same hydrophobicity as the target is hard to resolve. A second method that separates by a different property, such as hydrophilic interaction chromatography (HILIC) or ion exchange, or a detector that measures a different property, such as mass, can reveal what the first run missed. The Waters application note cited below proposes HILIC for exactly this reason.
For a certificate reader, the practical point is simple. A single HPLC purity figure is one view of the sample through one method. A purity figure supported by a mass result, or by a second separation, is a more complete view. Neither is wrong, but they carry different weight, and a careful comparison between suppliers should compare like with like rather than headline percentages alone.
How to use this when reading a certificate
- Find which method supports each claim: purity by HPLC, identity by MS or by retention time against a standard
- If identity is by MS, look for the theoretical and measured mass side by side
- If only HPLC is reported, treat identity as less strongly confirmed, unless a reference standard comparison is stated
- Look at the chromatogram for shoulders or unresolved humps on the main peak
- Remember that neither method addresses endotoxin, sterility or water content
Where Celyfe fits
Celyfe's published certificates, from Analiza Białek in Wrocław, report purity by HPLC: 99% for NAD+ Precision Pen batch A26085 and 99% for WOLVERINE (BPC-157 15mg + TB-500 15mg) batch C26071, both dated 2 October 2026. GLOW and KLOW certificates are being re-issued and are listed in the COA library at /coa when published. Reading them with the distinctions above in mind shows exactly what each one establishes.
Sources
Sources used for this guide, checked October 2026:
- D'Hondt M et al. Related impurities in peptide medicines. J Pharm Biomed Anal, December 2014. PMID 25044089
- Thermo Fisher Scientific: LC-UV/MS characterisation of the antimicrobial peptide LL-37, application note AN72818
- Agilent Technologies: Identification of synthetic peptide impurities by LC/MS/MS, application note 5994-2760EN
- Waters Corporation: LC-UV/MS workflows enabling orthogonal impurity profiling of GLP-1 analogs, application note 720009593, 2026
- Almac Group: LC-MS/MS identification of impurities present in synthetic peptide drugs (poster)
- Finnrick: How to read a certificate of analysis (COA), 1 March 2026
Research use only
Celyfe supplies research peptides for laboratory and research use only. Nothing on this page is guidance on use in humans or animals.
Research updates
Peptide research and testing, in your inbox
New batch certificates, regulation changes and a monthly digest of new published research on the compounds we cover. No spam, unsubscribe at any time.